Abstract
CHZ868 inhibits the proliferation of JAK2-mutant and type I JAK inhibitor–persistent cells.
©2015 American Association for Cancer Research.
2015
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 September 2015
Research Watch|
September 01 2015
A Type II JAK2 Inhibitor Is Active in JAK2-Dependent Malignancies Available to Purchase
Cancer Discov (2015) 5 (9): OF13.
RSS Feeds